Page last updated: 2024-08-25

bes and sirolimus

bes has been researched along with sirolimus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Cha, KS; Chae, IH; Choi, YJ; Hong, BK; Kang, SH; Kang, WC; Kim, MK; Kim, SH; Kwun, JS; Lee, JH; Lee, SH; Park, JJ; Rha, SW; Suh, JW; Yoon, CH; Youn, TJ1
Christensen, MK; Christiansen, EH; Ellert-Gregersen, J; Freeman, P; Hansen, KN; Jakobsen, L; Jensen, LO; Junker, A; Kahlert, J; Maeng, M; Noori, M; Raungaard, B; Terkelsen, CJ; Veien, KT1
Angiolillo, DJ; Baber, U; Cao, D; Cohen, DJ; Collier, T; Dangas, GD; Escaned, J; Franzone, A; Gibson, CM; Goel, R; Huber, K; Kastrati, A; Kaul, U; Kornowski, R; Krucoff, M; Kunadian, V; Mehran, R; Mehta, SR; Moliterno, D; Owen, R; Pocock, S; Sartori, S; Sharma, SK; Spirito, A; Steg, GP; Valgimigli, M; Vranckx, P; Windecker, S; Yaling, H; Zhang, Z1
Abe, M; Akasaka, T; Hanaoka, KI; Ikari, Y; Ishihara, T; Ishikawa, T; Kadota, K; Katoh, H; Kimura, T; Kozuma, K; Morimoto, T; Morino, Y; Muramatsu, T; Nakagawa, Y; Natsuaki, M; Nishikawa, H; Okada, K; Ono, K; Tamura, T; Tanabe, K; Taniguchi, R; Watanabe, H; Yamamoto, K1

Reviews

1 review(s) available for bes and sirolimus

ArticleYear
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.
    International journal of cardiology, 2023, 07-15, Volume: 383

    Topics: Absorbable Implants; Acute Coronary Syndrome; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Polymers; Sirolimus; Stents; Ticagrelor; Treatment Outcome

2023

Trials

3 trial(s) available for bes and sirolimus

ArticleYear
BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study.
    Circulation. Cardiovascular interventions, 2023, Volume: 16, Issue:1

    Topics: Absorbable Implants; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Percutaneous Coronary Intervention; Polymers; Prospective Studies; Prosthesis Design; Sirolimus; Treatment Outcome

2023
Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial.
    Circulation. Cardiovascular interventions, 2023, Volume: 16, Issue:1

    Topics: Absorbable Implants; Coronary Artery Disease; Drug-Eluting Stents; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Polymers; Prosthesis Design; Risk Factors; Sirolimus; Treatment Outcome

2023
Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT Trial.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2023, Aug-07, Volume: 19, Issue:5

    Topics: Absorbable Implants; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Follow-Up Studies; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Polymers; Sirolimus; Treatment Outcome

2023